pillbase.ru

ZEPOSIA

Active substance: ozanimod

CAPSULE · OZANIMOD HYDROCHLORIDE .92 mg/1

United StatesActive

Marketing holder: Celgene Corporation

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Zeposia
    ozanimod hydrochloride
    EMEA/H/C/004835
    Bristol-Myers Squibb Pharma EEIG
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1209b-5816-76f7-b68b-c2c2cb67e86d,01a1209b-581b-76ad-bf5f-c8d124069be9,01a1209b-5825-7d1c-b254-a72788d0526a;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
59572-820
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 59572-820 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 59572-820 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 59572-820 · Verified 2026-10-09 · open in source